BioVie
BIVI
38 hedge funds and large institutions have $1.02M invested in BioVie in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 8 closing their positions.
78% more capital inflows, than outflows
Capital inflows: $247K | Capital outflows: $138K
0.55% more ownership
Funds ownership: 5.38% → 5.92% (+0.55%)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
3% less funds holding
Funds holding: 39 → 38 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$71.5K |
| 2 |
Jane Street
New York
|
+$61K |
| 3 |
XTX Topco
George Town,
Cayman Islands
|
+$42.8K |
| 4 |
Two Sigma Securities
New York
|
+$22.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NewEdge Advisors
New Orleans,
Louisiana
|
-$53.3K |
| 2 |
Cerity Partners
New York
|
-$28.7K |
| 3 |
Two Sigma Investments
New York
|
-$21.2K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$12.7K |
| 5 |
HRT Financial
New York
|
-$10K |
BIVI Hedge Fund Activity: Q2 2025 in Review
38 of the 7,634 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q2 2025, worth a combined $1.02M — up 4.9% from $971K a quarter earlier.
Fund positioning in BIVI was balanced in Q2 2025: 8 funds opened new positions, 8 closed out, 8 added to existing stakes and 8 trimmed.
The largest buyer was UBS Group, adding an estimated $71.5K. The largest seller was NewEdge Advisors, cutting an estimated $53.3K.
- 38 institutional investors held BioVie (BIVI) as of Q2 2025, down from 39 in Q1 2025.
- Funds reported $1.02M of BioVie stock for Q2 2025, up 4.9% quarter-over-quarter.
- 8 funds opened new BioVie positions in Q2 2025 and 8 closed out, a net change of 0 holders.
- The largest BioVie buyer in Q2 2025 was UBS Group, an estimated $71.5K added.
- The largest BioVie seller in Q2 2025 was NewEdge Advisors, an estimated $53.3K sold.
Based on aggregated 13F filings for Q2 2025.